Biotech

All Articles

Actinogen's cortisol blocker stops working stage 2 anxiety study

.Actinogen Medical's cortisol blocker has actually missed the key endpoint of a phase 2 research in ...

Bivictrix chooses going exclusive only technique to take ADC into center

.Antibody-drug conjugates (ADCs) have actually been at the center of several a billion-dollar biobuc...

TPG tops up funds to $580M for financial investments across lifestyle sciences

.Possession manager TPG, which has actually supported biotechs such as Sionna Therapeutics as well a...

Merck ceases stage 3 TIGIT test in lung cancer for impossibility

.Merck &amp Co.'s TIGIT system has actually gone through another obstacle. Months after shuttering a...

After a difficult year, Exscientia folds up in to Recursion

.After a year specified through pipe hairstyles, the shift of its CEO as well as discharges, Exscien...

Cullinan, after $25M deal, restore bispecific to Port

.Cullinan Therapy was made an impression on sufficient along with Harbour BioMed's bispecific immune...

A closer check out Ferocious Biotech's Tough 15

.Within this week's incident of "The Best Pipe," our experts are actually diving in to Tough Biotech...

Lilly faces phase 2 breakdown of tau-targeting med

.The confetti is actually still soaring coming from Eli Lilly's party commemorating the approval of ...

Biogen CMO Maha Radhakrishnan participates in Sofinnova-- Chutes &amp Ladders

.Invite to today's Chutes &amp Ladders, our roundup of notable management hirings, firings as well a...

Lykos are going to talk to FDA to reevaluate its decision observing turndown of MDMA treatment for trauma

.Adhering to a bad showing for Lykos Therapeutics' MDMA candidate for post-traumatic stress disorder...